Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/26 16:05 | 7/16/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Warmuth Markus | MA | DO | P,CEO | 1 | S | -220 | 23.18 | 0 | -10 | 585 | D | |||||||||||||||
7/16/26 16:10 | 7/15/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Champoux Jennifer | MA | O | COO | 3 | S.d | -187 | 21.44 | 0 | -9 | 62 | D | |||||||||||||||
7/7/26 16:41 | 7/6/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Townson Sharon | MA | O | Chief Sc | 3 | S.d | -257 | 21.40 | 0 | -12 | 68 | D | |||||||||||||||
7/1/26 16:57 | 6/30/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Janku Filip | MA | O | Chief Me | 3 | S.dm | -1,152 | 21.64 | 0 | -53 | 61 | D | |||||||||||||||
6/30/26 16:05 | 6/29/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Manning Anthony M. | MA | D | 1 | S.d | -231 | 23.11 | 0 | -10 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |